1373215-15-6; LY3000328; LY 3000328; Cathepsin S Inhibitor; LY-3000328; Z-FL-COCHO; CHEMBL3342553; 1210T8CX6K; [(3R,4S)-4-[(4-fluorobenzoyl)amino]-6-[4-(oxetan-3-yl)piperazin-1-yl]-3,4-dihydro-2H-chromen-3-yl] N-methylcarbamate; (3r,4s)-4-[(4-Fluorobenzoyl)amino]-6-[4-(Oxetan-3-Yl)piperazin-1-Yl]-3,4-Dihydro-2h-Chromen-3-Yl Methylcarbamate; Benzamide, N-((3R,4S)-3,4-dihydro-3-(((methylamino)carbonyl)oxy)-6-(4-(3-oxetanyl)-1-piperazinyl)-2H-1-benzopyran-4-yl)-4-fluoro-; N-((3R,4S)-3,4-Dihydro-3-(((methylamino)carbonyl)oxy)-6-(4-(3-oxetanyl)-1-piperazinyl)-2H-1-benzopyran-4-yl)-4-fluorobenzamide; UNII-1210T8CX6K; SCHEMBL2618738; DTXSID40737323; BCP14297; EX-A2231; BDBM50030823; ZINC95641919; CS-1120; NCGC00378866-01; BS-15315; HY-15533; Cathepsin S inhibitorCathepsin S inhibitor; C72497; Q27452973; (3R,4S)-4-(4-fluorobenzamido)-6-(4-(oxetan-3-yl)piperazin-1-yl)chroman-3-yl methylcarbamate; (3R,4S)-4-(4-Fluorobenzamido)-6-[4-(oxetan-3-yl)piperazin-1-yl]-3,4-dihydro-2H-1-benzopyran-3-yl methylcarbamate; (3R,4S)-4-(4-fluorobenzamido)-6-[4-(oxetan-3-yl)piperazin-1-yl]-3,4-dihydro-2H-1-benzopyran-3-yl N-methylcarbamate; [(3R,4S)-4-[(4-Fluorobenzoyl)amino]-6-[4-(oxetan-3-yl)piperazin-1-yl]chroman-3-yl]N-methylcarbamate; 2FZ